Veterans Demand VA Formally Rescind Controversial Disability Rating Rule

The Department of Veterans Affairs (VA) is currently embroiled in a high-stakes regulatory standoff that could redefine disability compensation for hundreds of thousands of former service members. At the heart of the controversy is a rule published on February 17, 2026, which mandates that medical examiners consider the effectiveness of treatments or medications when determining a veteran’s disability rating. While VA Secretary Doug Collins has verbally committed to a policy of non-enforcement, the rule’s continued presence in the Federal Register has sparked a firestorm of criticism from veterans' advocacy groups and a bipartisan coalition of lawmakers.

The impetus for this regulatory shift stems from the 2025 judicial decision in Ingram v. Collins. This ruling has forced the VA to reconsider approximately 350,000 claims decisions, a massive administrative undertaking that requires the retraining of medical examiners. VA officials argue that the new rule is a necessary formalization of a practice that has existed since 1958, designed to ensure that compensation reflects the actual level of impairment a veteran experiences in daily life. From a fiscal perspective, the department warns that failing to account for treatment efficacy would lead to a significant increase in expenditures for disability levels that do not align with a veteran's current physical or mental state.

“

The Department of Veterans Affairs (VA) is currently embroiled in a high-stakes regulatory standoff that could redefine disability compensation for hundreds of thousands of former service members.

However, the workforce and social implications of such a shift are profound. Veterans and organizations like the Disabled American Veterans (DAV) view the rule as a betrayal and a penalty for healing. Coleman Nee, the DAV National Commander, articulated a sentiment shared by many: that veterans should not be financially penalized for successfully managing their conditions through medication or therapy. This creates a perverse incentive structure where veterans might fear that seeking effective treatment could lead to a reduction in the financial support they rely on for stability. For the broader workforce, this uncertainty can impact veteran retention and transition programs, as disability ratings often serve as a foundational element of a veteran's post-service economic security.

The scale of the public response is nearly unprecedented for a VA regulatory filing. As of late February, more than 18,000 comments have been logged in the Federal Register, the vast majority calling for immediate rescission. This grassroots pressure is mirrored in the halls of Congress, where over 20 lawmakers from the House and Senate Veterans Affairs Committees have formally requested that Secretary Collins revoke the rule. The primary concern among legislators is the legal limbo created by the current situation. A promise of non-enforcement from a current Secretary is not legally binding on future administrations or even current subordinates, leaving the door open for inconsistent application of the law.